Exibral Jarabe

Array
(
    [ID] => 1168
    [post_author] => 16
    [post_date] => 2012-06-06 18:25:19
    [post_date_gmt] => 2012-06-06 18:25:19
    [post_content] => 
Forma Farmacéutica:
Jarabe
Composición:
Cada 100 ml de jarabe contienen:
Ácido Valproico 5 g (como Valproato de Sodio)
Acción Terapéutica:
Anticonvulsivante.
Indicaciones:
Epilepsia: EXIBRAL está indicado como monoterapia y tratamiento combinado en pacientes con crisis epilépticas de ausencia simples y complejas y como tratamiento combinado en pacientes con crisis múltiples que incluyen crisis de ausencia.
Presentaciones:
Envases conteniendo 120 ml.
    [post_title] => Exibral Jarabe
    [post_excerpt] => Anticonvulsivante.
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => exibral
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2024-10-14 11:38:04
    [post_modified_gmt] => 2024-10-14 14:38:04
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://www.bago.com.ar/vademecum//?post_type=productos&p=1168
    [menu_order] => 0
    [post_type] => productos
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
    [prospecto_para_pacientes] => Array
        (
        )

    [url_para_mayor_informacion_video] => 
    [url_para_mayor_informacion] => 
    [url_productos_consumo_masivo] => 
    [prospecto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 1169
                    [post_author] => 16
                    [post_date] => 2012-06-06 18:23:08
                    [post_date_gmt] => 2012-06-06 18:23:08
                    [post_content] => 
                    [post_title] => exibral_jarabe_anmat_0541_05.pdf
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => open
                    [post_password] => 
                    [post_name] => exibral_jarabe_anmat_0541_05-pdf
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2012-06-06 18:23:08
                    [post_modified_gmt] => 2012-06-06 18:23:08
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => 
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [presentacion_img] => Array
        (
        )

    [logo_img] => Array
        (
        )

    [foto_producto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 12870
                    [post_author] => 16
                    [post_date] => 2017-01-20 09:08:21
                    [post_date_gmt] => 2017-01-20 12:08:21
                    [post_content] => 
                    [post_title] => Exibral_AV
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => exibral_av-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2017-01-20 09:08:21
                    [post_modified_gmt] => 2017-01-20 12:08:21
                    [post_content_filtered] => 
                    [post_parent] => 1168
                    [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2012/06/Exibral_AV.png
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/png
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [fotos_lanzamiento] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 12870
                    [post_author] => 16
                    [post_date] => 2017-01-20 09:08:21
                    [post_date_gmt] => 2017-01-20 12:08:21
                    [post_content] => 
                    [post_title] => Exibral_AV
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => exibral_av-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2017-01-20 09:08:21
                    [post_modified_gmt] => 2017-01-20 12:08:21
                    [post_content_filtered] => 
                    [post_parent] => 1168
                    [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2012/06/Exibral_AV.png
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/png
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [especialidad] => Array
        (
        )

    [marca] => Array
        (
            [0] => Exibral
        )

    [principio_activo] => Array
        (
            [0] => Ácido Valproico
        )

    [post_content_formatted] => 
Forma Farmacéutica:
Jarabe
Composición:
Cada 100 ml de jarabe contienen:

Ácido Valproico 5 g (como Valproato de Sodio)
Acción Terapéutica:
Anticonvulsivante.
Indicaciones:
Epilepsia: EXIBRAL está indicado como monoterapia y tratamiento combinado en pacientes con crisis epilépticas de ausencia simples y complejas y como tratamiento combinado en pacientes con crisis múltiples que incluyen crisis de ausencia.
Presentaciones:
Envases conteniendo 120 ml.

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => prospectos/exibral_jarabe_anmat_0541_05.pdf
        )

)

anexo_congre_single